MPG.eBooks - Search Results

181

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric...

Published 2020

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that iron isomaltoside 1000 (Monoferric...”

Read Now

182

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Read Now

183

CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee recommends that nintedanib be reimbursed for the treatment...”

Read Now

184

CADTH Canadian Drug Expert Committee recommendation: Caplacizumab (Cablivi -- Sanofi-Aventis Canada...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Read Now

185

CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that dapagliflozin (Forxiga) should...”

Read Now

186

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.)...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that ixekizumab be reimbursed...”

Read Now

187

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.)...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that baricitinib be reimbursed for use...”

Read Now

188

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche...

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that ocrelizumab be reimbursed...”

Read Now

189

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV...

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that dolutegravir/rilpivirine (DTG/RPV...”

Read Now

190

CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Read Now

191

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Read Now

192

CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire...

Published 2019

CADTH

Read Now

193

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.)...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that nitisinone (MDK-Nitisinone...”

Read Now

194

CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that lixisenatide be reimbursed for use...”

Read Now

195

CADTH Canadian Drug Expert Committee recommendation: Ofatumumab (Kesimpta -- Novartis...

Published 2021

Canadian Agency for Drugs and Technologies in Health

Read Now

196

CADTH Canadian Drug Expert Committee recommendation: Icosapent ethyl (Vascepa -- HLS Therapeutics...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that icosapent ethyl be reimbursed...”

Read Now

197

CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada...

Published 2020

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that tafamidis be reimbursed...”

Read Now

198

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric...

Published 2020

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that iron isomaltoside 1000 (Monoferric...”

Read Now

199

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier...

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee recommendation...”

Read Now

200

Olopatadine for the treatment of allergic conjunctivitis : a review of the clinical efficacy, safety, and cost-effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Narrow Search